Smart Money Is Buying Nabriva Therapeutics plc (NBRV)
Is Nabriva Therapeutics plc (NASDAQ:NBRV) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Nabriva Therapeutics Legacy Plc (NBRV)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (NBRVF) is currently associated with the following stock: Nabriva Therapeutics Plc (NBRVF)
Sector: Healthcare
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.50 | 23,445 | $246,172.50 | 2,397,922 | 2017-07-20 | Filing | |
| $10.50 | 20,786 | $218,253.00 | 2,421,367 | 2017-07-19 | Filing | |
| $10.50 | 1,339 | $14,059.50 | 2,442,153 | 2017-07-18 | Filing | |
| $10.50 | 47,460 | $498,415.43 | 2,443,492 | 2017-07-17 | Filing | |
| $10.53 | 21,055 | $221,789.16 | 2,490,952 | 2017-07-14 | Filing |
News See All
3 Small-Cap Biotech Stocks That Could be Poised to Explode
With the threat of severe drug pricing regulations behind it for now, the biotech sector has launched a rally in recent days, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) gaining over...
These Two Healthcare Stocks Receive A Vote Of Confidence From Elite Hedge Fund Managers
As U.S equities have plummeted on global-growth worries, confident hedge funds and other investors have started piling up more shares of companies that are trading on the cheap.
Hedge Fund Resource Center